UK markets close in 2 hours 52 minutes
  • FTSE 100

    7,394.71
    -126.97 (-1.69%)
     
  • FTSE 250

    20,571.90
    -309.90 (-1.48%)
     
  • AIM

    1,032.60
    -16.42 (-1.57%)
     
  • GBP/EUR

    1.1859
    -0.0029 (-0.24%)
     
  • GBP/USD

    1.2741
    -0.0093 (-0.73%)
     
  • BTC-GBP

    30,563.10
    -662.56 (-2.12%)
     
  • CMC Crypto 200

    904.65
    -40.92 (-4.33%)
     
  • S&P 500

    4,271.78
    -121.88 (-2.77%)
     
  • DOW

    33,811.40
    -981.40 (-2.82%)
     
  • CRUDE OIL

    97.41
    -4.66 (-4.57%)
     
  • GOLD FUTURES

    1,895.40
    -38.90 (-2.01%)
     
  • NIKKEI 225

    26,590.78
    -514.48 (-1.90%)
     
  • HANG SENG

    19,869.34
    -769.18 (-3.73%)
     
  • DAX

    13,987.25
    -154.84 (-1.09%)
     
  • CAC 40

    6,470.80
    -110.62 (-1.68%)
     

Global Apheresis Equipment Market to Reach $2.9 Billion by 2024

·25-min read
ReportLinker
ReportLinker

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, April 25, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Apheresis Equipment Industry" - https://www.reportlinker.com/p05112906/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Apheresis Equipment Market to Reach $2.9 Billion by 2024

Apheresis refers to a procedure where blood from a person (patient or donor) is passed through a medical device in order to extract the required components, such as red blood cells, platelets, plasma and others, by employing centrifugation or membrane filtration technologies, and later returned to circulation with or without extracorporeal treatment. The increasing prevalence of blood disorders such as sickle cell anemia, blood cancer, and hemophilia and the rising need for various blood products is driving the demand for apheresis equipment, globally. Amid the COVID-19 crisis, the global market for Apheresis Equipment is projected to reach US$2.9 Billion by 2024, registering a compounded annual growth rate (CAGR) of 8.8% over the analysis period. United States represents the largest regional market for Apheresis Equipment, accounting for an estimated 34.6% share of the global total. The market is projected to reach US$1.1 Billion by the close of the analysis period. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 12.3% over the analysis period.

Sustained rise in demand for blood components, increasing incidence of chronic conditions such as cardiovascular disease, leukemia and sickle cell anemia, and the growing use of apheresis for the treatment of cancer are enhancing the need for apheresis equipment. Growth is also attributed to the advantages offered by apheresis collection compared to whole blood collection, and the escalating demand for plasma from biopharmaceutical companies for use in plasma fractionation. Constant shortage of blood and the need to ensure safety of blood being supplied is also driving focus onto apheresis blood. However, shortage of blood donors, high equipment cost, shortage of trained technicians and histocompatibility issues are impeding market growth. North America remains the largest market for apheresis equipment due to factors such as high patient spending levels, availability of advanced healthcare infrastructure facilities, and relatively higher levels of awareness among patients. Government support, favorable reimbursement policies and availability of advanced blood collection technologies are favoring market growth in developed markets. Europe is also a major contributor to the apheresis market over the years, led by rising consumer awareness levels, increasing willingness to donate blood and increasing prevalence of chronic disorders. The promising outlook for Asia-Pacific region is attributed primarily to the rising prevalence of blood-related disorders in emerging economies of China and India.
Select Competitors (Total 24 Featured) -

  • Asahi Kasei Medical Co., Ltd.

  • B Braun Melsungen AG

  • Cerus Corporation

  • Fresenius Kabi AG

  • Haemonetics Corporation

  • Kaneka Corporation

  • Kawasumi Laboratories, Inc.

  • Mallinckrodt Pharmaceuticals

  • Medica SpA

  • NIKKISO Europe GmbH

  • Terumo BCT, Inc.




Read the full report: https://www.reportlinker.com/p05112906/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Apheresis Equipment: An Introductory Prelude
Bright Prospects Ahead for Apheresis Equipment Market
Developed Regions Emerge as Primary Contributors to Apheresis
Equipment Sales
Developing Regions to Spearhead Future Growth
Rise in Healthcare Spending Creates Fertile Environment for
Apheresis Equipment Market
World Healthcare Expenditure (In US$ Trillion) for the Years
2017, 2019, 2021 and 2023
Per Capita Healthcare Expenditure (in $) by Select Countries
for 2018
Sustained Increase in Blood & Plasma Collection Programs
Instigates Substantial Opportunities
Blood Components and Plasma Consumption (in ’000 Units) by
Region for 2016, 2019 and 2022
Red Blood Cells Consumption (in ’000 Units) by Region for 2016,
2019 and 2022
Blood Supply Shortage & Safety Concerns Promote New Demand
Critical Importance of Plasma-Based Products in Diagnostic &
Therapeutic Applications Builds Momentum
Resolving Prevailing Issues & Challenges Vital for Apheresis
Equipment Market
Apheresis Equipment - Global Key Competitors Percentage Market
Share in 2022 (E)
Consolidation of Blood Collectors & Healthcare Providers Puts
Pricing Pressure on Suppliers
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Incidence of Blood Disorders Fuels Need for Apheresis
Procedures and Equipment
Blood Disorders Incidence Worldwide: Number of People Suffering
from Hemophilia, von Willebrand, and Other Disorders (2019)
Market Benefits from Increasing Prevalence of Chronic
Disorders, Rise in Surgical Procedures and Trauma & Injury
Cases
Global Cost of Chronic Diseases (In US$ Billion) for the Years
2018 and 2030
Global Surgical Procedure Volume by Procedure Type (2018)
Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Total Number of New Cancer Cases by Type: 2018
Cancer Incidence by Region: 2018
Cancer Mortality by Region: 2018
Plasmapheresis: The Primary Procedure Type
Off-Label Indications Expand Adoption of Photopheresis Procedure
Plateletpheresis Extends a Handy Tool for Dealing with Bleeding
Disorders in Surgeries
Donor Apheresis Equipment Market: High Growth in Store
Global Blood Donations: Apheresis Donation as % of Total Blood
Donation by Region
Therapeutic Apheresis Equipment Poised for Significant Growth
Disposable Apheresis Kits Market Benefits from Single-Use
Nature of Products
Centrifugation Technology and Membrane Filtration Promise Growth
Neurology: The Major Application Area for Apheresis Equipment
Technological Advancements and Novel Indications Augur Well
Innovations in Hybrid Devices Gather Steam
New Apheresis Technologies Emerge to Meet Growing Demand for
Plasma-based Therapies
Pediatrics: An Unexplored Domain in Therapeutic Apheresis
Challenges for Therapeutic Apheresis in Pediatrics Segment
Automated Blood Processing Systems in Open Heart Surgeries
CFA: An Effective Way to Pull Up Cold Hemagglutinin Disease
Aging Population: A Strong Growth Driver
Global Aging Population: Population of 65+ Individuals
(in Thousands) by Region for 2019 and 2030
Elderly Population (65+ Years) as a % of Total Population by
Developed, Less Developed and Least Developed Regions: 2019 &
2030
Life Expectancy at Birth (in Years) in Select Countries for 2020E
TECHNOLOGY OVERVIEW
Apheresis: An Introduction
Apheresis Vs. Whole Blood Collection
Apheresis Process: An Overview
Types of Apheresis Procedures
Photopheresis
Plasmapheresis
Facts About Plasma and its Donation
Pre-requisites for Plasma Donors
Sources of Blood Plasma
Plasma Exchange and Plasmapheresis: The Difference
Therapeutic Plasma Exchange (TPE) or Plasma Exchange
Plasmapheresis: Potential Uses Discovered in the Early Years
Erythrocytapheresis
Plateletpheresis
Leukapheresis
LDL-Apheresis (Lipidpheresis)
Cytapheresis
Stem Cell Collection
Types of Apheresis Equipment
Donor Apheresis
Therapeutic Apheresis: An Introduction
Therapeutic Apheresis Techniques
Applications of Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Therapeutic Apheresis: A Treatment Option for Various Diseases
Indications for Therapeutic Apheresis
Type of Therapeutic Apheresis Procedure Used in Different
Medication Conditions
Emerging Applications of Therapeutic Apheresis
Therapeutic Apheresis: What is the Risk Involved?
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP)
Replacement
Blood Components & Derivatives
Blood: The Circulating Tissue of Human Body
Types of Blood
General Facts about Blood
General Uses of Blood
Components of Blood
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Platelets
Plasma

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Apheresis Equipment by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Apheresis Equipment by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Apheresis Equipment by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Disposable Apheresis Kits by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Disposable Apheresis Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Disposable Apheresis
Kits by Geographic Region - Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Plasma & Component Separator by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Plasma & Component Separator
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Plasma & Component
Separator by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 10: World Recent Past, Current & Future Analysis for
Other Types by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Other Types by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Other Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Centrifugation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Centrifugation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Centrifugation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Membrane Filtration by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Membrane Filtration by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Membrane Filtration by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Plasmapheresis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Plasmapheresis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Plasmapheresis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Plateletpheresis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Plateletpheresis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Plateletpheresis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Erythrocytapheresis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Erythrocytapheresis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Erythrocytapheresis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Other Procedures by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Other Procedures by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Other Procedures by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Neurology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Neurology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Neurology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 34: World Recent Past, Current & Future Analysis for
Hematology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Hematology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Hematology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 37: World Recent Past, Current & Future Analysis for
Renal Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 38: World Historic Review for Renal Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: World 15-Year Perspective for Renal Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 40: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 41: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 43: World Recent Past, Current & Future Analysis for
Leukapheresis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 44: World Historic Review for Leukapheresis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 45: World 15-Year Perspective for Leukapheresis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Apheresis Equipment Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
United States: An Important Market for Apheresis Equipment
Donor Apheresis Equipment and Therapeutic Apheresis Equipment
Markets
Demand for Plasma-based Therapies Fuels Adoption of
Plasmapheresis Devices
Blood & Plasma Donations in the US: An Overview
Blood Donations
Blood Transfusions per 1000 population in the US (2012-2018)
Blood Donation in the US: Breakdown of Blood Donations (in % by
Apheresis Donation and Whole Blood Donation
Blood Supply and Demand in the US: A Fact Sheet
Plasma Donations
Plasma Collection (in Million Liters) in the US for 2012, 2014,
2016 and 2018
Number of Blood Plasma Collections (in Million) in the US for
the Years 2012, 2014, 2016 and 2018
An Overview of Regulatory Environment and Reimbursement Scenario
Reimbursement Policies to Create Growth Opportunities for
Therapeutic Apheresis
Medicaid Coverage for Therapeutic Plasma Exchange
Payment Rates for Apheresis Procedures (in US$) for the Years
2018 and 2019
Competitive Scenario
US Whole Blood Collection Market: Breakdown of Volume Sales
(in %) by Company
US Market for Therapeutic Apheresis in Neurological Disorders:
Revenue Breakdown (in %) by Player for 2019
US Market for Therapeutic Apheresis in Hematology and Oncology
Disorders: Revenue Breakdown (in %) by Company for 2019
Table 46: USA Recent Past, Current & Future Analysis for
Apheresis Equipment by Type - Disposable Apheresis Kits, Plasma &
Component Separator and Other Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: USA Historic Review for Apheresis Equipment by Type -
Disposable Apheresis Kits, Plasma & Component Separator and
Other Types Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 48: USA 15-Year Perspective for Apheresis Equipment by
Type - Percentage Breakdown of Value Sales for Disposable
Apheresis Kits, Plasma & Component Separator and Other Types
for the Years 2012, 2021 & 2027

Table 49: USA Recent Past, Current & Future Analysis for
Apheresis Equipment by Technology - Centrifugation and Membrane
Filtration - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: USA Historic Review for Apheresis Equipment by
Technology - Centrifugation and Membrane Filtration Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: USA 15-Year Perspective for Apheresis Equipment by
Technology - Percentage Breakdown of Value Sales for
Centrifugation and Membrane Filtration for the Years 2012, 2021 &
2027

Table 52: USA Recent Past, Current & Future Analysis for
Apheresis Equipment by Procedure - Plasmapheresis,
Plateletpheresis, Leukapheresis, Erythrocytapheresis and Other
Procedures - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: USA Historic Review for Apheresis Equipment by
Procedure - Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: USA 15-Year Perspective for Apheresis Equipment by
Procedure - Percentage Breakdown of Value Sales for
Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures for the Years 2012,
2021 & 2027

Table 55: USA Recent Past, Current & Future Analysis for
Apheresis Equipment by Application - Neurology, Hematology,
Renal Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: USA Historic Review for Apheresis Equipment by
Application - Neurology, Hematology, Renal Diseases and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: USA 15-Year Perspective for Apheresis Equipment by
Application - Percentage Breakdown of Value Sales for
Neurology, Hematology, Renal Diseases and Other Applications
for the Years 2012, 2021 & 2027

CANADA
Table 58: Canada Recent Past, Current & Future Analysis for
Apheresis Equipment by Type - Disposable Apheresis Kits, Plasma &
Component Separator and Other Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Canada Historic Review for Apheresis Equipment by
Type - Disposable Apheresis Kits, Plasma & Component Separator
and Other Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Apheresis Equipment by
Type - Percentage Breakdown of Value Sales for Disposable
Apheresis Kits, Plasma & Component Separator and Other Types
for the Years 2012, 2021 & 2027

Table 61: Canada Recent Past, Current & Future Analysis for
Apheresis Equipment by Technology - Centrifugation and Membrane
Filtration - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: Canada Historic Review for Apheresis Equipment by
Technology - Centrifugation and Membrane Filtration Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: Canada 15-Year Perspective for Apheresis Equipment by
Technology - Percentage Breakdown of Value Sales for
Centrifugation and Membrane Filtration for the Years 2012, 2021 &
2027

Table 64: Canada Recent Past, Current & Future Analysis for
Apheresis Equipment by Procedure - Plasmapheresis,
Plateletpheresis, Leukapheresis, Erythrocytapheresis and Other
Procedures - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Canada Historic Review for Apheresis Equipment by
Procedure - Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 66: Canada 15-Year Perspective for Apheresis Equipment by
Procedure - Percentage Breakdown of Value Sales for
Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures for the Years 2012,
2021 & 2027

Table 67: Canada Recent Past, Current & Future Analysis for
Apheresis Equipment by Application - Neurology, Hematology,
Renal Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Canada Historic Review for Apheresis Equipment by
Application - Neurology, Hematology, Renal Diseases and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Canada 15-Year Perspective for Apheresis Equipment by
Application - Percentage Breakdown of Value Sales for
Neurology, Hematology, Renal Diseases and Other Applications
for the Years 2012, 2021 & 2027

JAPAN
Apheresis Equipment Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Therapeutic Apheresis Market in Japan: An Overview
Growing Demand for Cancer Treatments Drives Plateletpheresis
Market
Table 70: Japan Recent Past, Current & Future Analysis for
Apheresis Equipment by Type - Disposable Apheresis Kits, Plasma &
Component Separator and Other Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: Japan Historic Review for Apheresis Equipment by Type -
Disposable Apheresis Kits, Plasma & Component Separator and
Other Types Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Japan 15-Year Perspective for Apheresis Equipment by
Type - Percentage Breakdown of Value Sales for Disposable
Apheresis Kits, Plasma & Component Separator and Other Types
for the Years 2012, 2021 & 2027

Table 73: Japan Recent Past, Current & Future Analysis for
Apheresis Equipment by Technology - Centrifugation and Membrane
Filtration - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 74: Japan Historic Review for Apheresis Equipment by
Technology - Centrifugation and Membrane Filtration Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: Japan 15-Year Perspective for Apheresis Equipment by
Technology - Percentage Breakdown of Value Sales for
Centrifugation and Membrane Filtration for the Years 2012, 2021 &
2027

Table 76: Japan Recent Past, Current & Future Analysis for
Apheresis Equipment by Procedure - Plasmapheresis,
Plateletpheresis, Leukapheresis, Erythrocytapheresis and Other
Procedures - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 77: Japan Historic Review for Apheresis Equipment by
Procedure - Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 78: Japan 15-Year Perspective for Apheresis Equipment by
Procedure - Percentage Breakdown of Value Sales for
Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures for the Years 2012,
2021 & 2027

Table 79: Japan Recent Past, Current & Future Analysis for
Apheresis Equipment by Application - Neurology, Hematology,
Renal Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Japan Historic Review for Apheresis Equipment by
Application - Neurology, Hematology, Renal Diseases and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Japan 15-Year Perspective for Apheresis Equipment by
Application - Percentage Breakdown of Value Sales for
Neurology, Hematology, Renal Diseases and Other Applications
for the Years 2012, 2021 & 2027

CHINA
Apheresis Equipment Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 82: China Recent Past, Current & Future Analysis for
Apheresis Equipment by Type - Disposable Apheresis Kits, Plasma &
Component Separator and Other Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: China Historic Review for Apheresis Equipment by Type -
Disposable Apheresis Kits, Plasma & Component Separator and
Other Types Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: China 15-Year Perspective for Apheresis Equipment by
Type - Percentage Breakdown of Value Sales for Disposable
Apheresis Kits, Plasma & Component Separator and Other Types
for the Years 2012, 2021 & 2027

Table 85: China Recent Past, Current & Future Analysis for
Apheresis Equipment by Technology - Centrifugation and Membrane
Filtration - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: China Historic Review for Apheresis Equipment by
Technology - Centrifugation and Membrane Filtration Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: China 15-Year Perspective for Apheresis Equipment by
Technology - Percentage Breakdown of Value Sales for
Centrifugation and Membrane Filtration for the Years 2012, 2021 &
2027

Table 88: China Recent Past, Current & Future Analysis for
Apheresis Equipment by Procedure - Plasmapheresis,
Plateletpheresis, Leukapheresis, Erythrocytapheresis and Other
Procedures - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: China Historic Review for Apheresis Equipment by
Procedure - Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 90: China 15-Year Perspective for Apheresis Equipment by
Procedure - Percentage Breakdown of Value Sales for
Plasmapheresis, Plateletpheresis, Leukapheresis,
Erythrocytapheresis and Other Procedures for the Years 2012,
2021 & 2027

Table 91: China Recent Past, Current & Future Analysis for
Apheresis Equipment by Application - Neurology, Hematology,
Renal Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: China Historic Review for Apheresis Equipment by
Application - Neurology, Hematology, Renal Diseases and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: China 15-Year Perspective for Apheresis Equipment by
Application - Percentage Breakdown of Value Sales for
Neurology, Hematology, Renal Diseases and Other Applications
for the Years 2012, 2021 & 2027

EUROPE
Apheresis Equipment Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Europe: A Major Market for Apheresis Equipment
Plasma Collection (in Million Liters) in Europe for 2012, 2014,
2016 and 2018
Table 94: Europe Recent Past, Current & Future Analysis for
Apheresis Equipment by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 95: Europe Historic Review for Apheresis Equipment by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 96: Europe 15-Year Perspective for Apheresis Equipment by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 97: Europe Recent Past, Current & Future Analysis for
Apheresis Equipment by Type - Disposable Apheresis Kits, Plasma &
Component Separator and Other Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Europe Historic Review for Apheresis Equipment by
Type - Disposable Apheresis Kits, Plasma & Component Separator
and Other Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Europe 15-Year Perspective for Apheresis Equipment by
Type - Percentage Breakdown of Value Sales for Disposable
Apheresis Kits, Plasma & Component Separator and Other Types
for the Years 2012, 2021 & 2027

Table 100: Europe Recent Past, Current & Future Analysis for
Apheresis Equipment by Technology - Centrifugation and Membrane

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05112906/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting